Ranjit Kumar Goudar

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint New therapeutic options for mesothelioma
    Ranjit Kumar Goudar
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Curr Oncol Rep 7:260-5. 2005
  2. ncbi request reprint Hypoxia, angiogenesis, and lung cancer
    Ranjit K Goudar
    Department of Medicine, Duke University Medical Center, Box 3841, Durham, NC 27710, USA
    Curr Oncol Rep 10:277-82. 2008
  3. ncbi request reprint Management options for malignant pleural mesothelioma: clinical and cost considerations
    Ranjit K Goudar
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27701, USA
    Drugs 67:1149-65. 2007
  4. ncbi request reprint Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)
    Momen M Wahidi
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 3683, Durham, NC 27710, USA
    Chest 132:94S-107S. 2007

Detail Information

Publications4

  1. ncbi request reprint New therapeutic options for mesothelioma
    Ranjit Kumar Goudar
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Curr Oncol Rep 7:260-5. 2005
    ....
  2. ncbi request reprint Hypoxia, angiogenesis, and lung cancer
    Ranjit K Goudar
    Department of Medicine, Duke University Medical Center, Box 3841, Durham, NC 27710, USA
    Curr Oncol Rep 10:277-82. 2008
    ..Combinations of antiangiogenic drugs and conventional cytotoxic chemotherapy are currently under development...
  3. ncbi request reprint Management options for malignant pleural mesothelioma: clinical and cost considerations
    Ranjit K Goudar
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27701, USA
    Drugs 67:1149-65. 2007
    ..MPM treatment is a costly public health issue; after efficacy is proven, additional studies are needed to measure the cost effectiveness of MPM treatment regimens...
  4. ncbi request reprint Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)
    Momen M Wahidi
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 3683, Durham, NC 27710, USA
    Chest 132:94S-107S. 2007
    ..The solitary pulmonary nodule (SPN) is a frequent incidental finding that may represent primary lung cancer or other malignant or benign lesions. The optimal management of the SPN remains unclear...